Scholars@Duke

SHock Inhibition Evaluation with AzimiLiDe (SHIELD): A randomized placebo controlled trial of azimilide in reducing ICD therapies

Publication ,  Conference
Dorian, P; Hohnloser, S; Al-Khalidi, HR; Brum, JM; Borggrefe, M; Tatla, DS; Brachmann, J; Myerburg, R; Cannom, D; Vanderlaan, M; Holroyde, MJ ...
Published in: CIRCULATION
April 5, 2005
Link to item

Duke Scholars

Hussein Rashid Al-Khalidi
Author Hussein Rashid Al-Khalidi Biostatistics & Bioinformatics, Division of Biostatistics

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

April 5, 2005

Volume

111

Issue

13

Start / End Page

1726 / 1726

Location

New Orleans, LA

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

77th Scientific Meeting of the American-Heart-Association

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dorian, P., Hohnloser, S., Al-Khalidi, H. R., Brum, J. M., Borggrefe, M., Tatla, D. S., … Pratt, C. M. (2005). SHock Inhibition Evaluation with AzimiLiDe (SHIELD): A randomized placebo controlled trial of azimilide in reducing ICD therapies. In CIRCULATION (Vol. 111, pp. 1726–1726). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS.
Dorian, P., S. Hohnloser, H. R. Al-Khalidi, J. M. Brum, M. Borggrefe, D. S. Tatla, J. Brachmann, et al. “SHock Inhibition Evaluation with AzimiLiDe (SHIELD): A randomized placebo controlled trial of azimilide in reducing ICD therapies.” In CIRCULATION, 111:1726–1726. LIPPINCOTT WILLIAMS & WILKINS, 2005.
Dorian P, Hohnloser S, Al-Khalidi HR, Brum JM, Borggrefe M, Tatla DS, et al. SHock Inhibition Evaluation with AzimiLiDe (SHIELD): A randomized placebo controlled trial of azimilide in reducing ICD therapies. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2005. p. 1726–1726.
Dorian, P., et al. “SHock Inhibition Evaluation with AzimiLiDe (SHIELD): A randomized placebo controlled trial of azimilide in reducing ICD therapies.” CIRCULATION, vol. 111, no. 13, LIPPINCOTT WILLIAMS & WILKINS, 2005, pp. 1726–1726.
Dorian P, Hohnloser S, Al-Khalidi HR, Brum JM, Borggrefe M, Tatla DS, Brachmann J, Myerburg R, Cannom D, Vanderlaan M, Holroyde MJ, Pratt CM. SHock Inhibition Evaluation with AzimiLiDe (SHIELD): A randomized placebo controlled trial of azimilide in reducing ICD therapies. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2005. p. 1726–1726.

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

April 5, 2005

Volume

111

Issue

13

Start / End Page

1726 / 1726

Location

New Orleans, LA

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

77th Scientific Meeting of the American-Heart-Association

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology